Aigen Investment Management, LP Zai Lab LTD Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$23.14 - $49.68 $127,316 - $273,339	-5,502 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$27.77 - $64.4 $54,817 - $127,125	1,974 Added 55.95%	5,502 $242,000
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $193,687 - $371,180	3,528 New	3,528 $218,000
Q4 2020 Feb 12, 2021	SELL	$81.94 - $135.34 $983 - $1,624	-12 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$73.3 - $89.48 $879 - $1,073	12 New	12 $1,000
Q1 2020 May 08, 2020	SELL	$39.1 - $62.9 $21,270 - $34,217	-544 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$29.79 - $43.06 $16,205 - $23,424	544 New	544 $23,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.62B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.